[ Inglês] What Are the Long-Term Effects of Myeloma Treatment?

Published on

Topics include: Ask the Expert

At a recent town meeting in Atlanta, an audience member wants to know more about the long-term effects of the multiple myeloma therapy lenalidomide (Revlimid) on the body. Myeloma expert Dr. Jonathan Kaufman, from the Winship Cancer Institute, responds by explaining potential risks for patients on maintenance therapy and shares how patients can stay proactive throughout their treatment journey. 

This town meeting is sponsored by Amgen, Janssen Pharmaceuticals and Adaptive Biotechnologies. It is produced by Patient Power in partnership with Winship Cancer Institute of Emory University.

View more programs featuring and

Produced in association with Winship Cancer Institute

Transcript

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

Audience Member:

Now, having said that, having myeloma, now that patients are living a long time, having myeloma or being on Revlimid doesn't protect you from getting other cancers, and everybody should still do their age-appropriate screening for other cancers.  

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

Related Programs

Hope and Progress in CAR-T Cell Therapy for Myeloma

Watch as myeloma expert Dr. Jonathan Kaufman shares developments in CAR-T cell therapy and challenges patients may face with the therapy.

Published:

How Do Young Adults With Multiple Myeloma Tolerate Treatment?

Do younger myeloma patients respond to treatment differently? Tune in to hear myeloma experts Dr. Jonathan Kaufman and Dr. Rafael Fonseca share their knowledge.

Published:

How Do I Best Evaluate Myeloma Treatment Options After Relapse?

What course of action should myeloma patients take after a relapse? Does the nature of relapse vary from patient to patient? Watch now to hear experts Dr. Jonathan Kaufman and Dr. Rafael Fonseca explain.

Published:

Advertisement
Junte-se a nossa comunidade Cadastre-se para Eventos Leia nosso último blog
Advertisement

Page last updated on September 9, 2019